Blockchain Registration Transaction Record

DOJ Reschedules Marijuana Products: A Historic Shift

DOJ reschedules marijuana products to Schedule III, easing federal restrictions. Curaleaf and other cannabis companies may benefit from reduced regulatory hurdles. Read more.

This rescheduling matters because it removes cannabis from the most restrictive Schedule I category, potentially easing federal barriers for research, banking, and business operations. For investors, it signals a more favorable regulatory environment that could unlock growth opportunities for companies like Curaleaf. However, the full impact hinges on future rulemaking and whether broader reforms follow, making this a pivotal moment for the cannabis industry.